Patents by Inventor Xinan XIU

Xinan XIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210062269
    Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments that have likely benefit for a cancer, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease. The molecular profiling can be used to identify likely have lack of benefit for treating the cancer.
    Type: Application
    Filed: June 15, 2020
    Publication date: March 4, 2021
    Inventors: Gargi Basu, David Arguello, Rebecca Feldman, Xinan Xiu, Zoran Gatalica
  • Publication number: 20200299774
    Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments that have likely benefit for a cancer, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease. The molecular profiling can be used to identify likely have lack of benefit for treating the cancer.
    Type: Application
    Filed: October 9, 2019
    Publication date: September 24, 2020
    Applicant: Caris MPI, Inc.
    Inventors: Gargi BASU, David ARGUELLO, Rebecca FELDMAN, Xinan XIU, Zoran GATALICA
  • Publication number: 20150307947
    Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments that have likely benefit for a cancer, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease. The molecular profiling can be used to identify likely have lack of benefit for treating the cancer.
    Type: Application
    Filed: December 4, 2013
    Publication date: October 29, 2015
    Inventors: Gargi BASU, David ARGUELLO, Rebecca FELDMAN, Xinan XIU, Zoran GATALICA